Translate
Xeris Biopharma Holdings, Inc.
About
6.19USD-0.19 -2.98%
Closed • Updated at 13:18 GMT+00:00Market Cap$1.07B
P/E Ratio94.50
Volume1.09M
Beta1.77
RSI50.06
Gross Margin82.45%
Xeris Biopharma Holdings, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Xeris Biopharma Reports First Quarter 2026 Financial Results
Apr 23 2026
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 2 2026
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
Feb 26 2026
Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit
Feb 17 2026
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
Recent Videos
Cómo invertir en Xeris Biopharma Holdings Inc (XERS) paso a paso
Mar 25, 2026
Xeris Pharmaceuticals XERS 2026 Summary 09Mar2026
Mar 09, 2026
Xeris Biopharma Holdings Inc. 2025 annual report
Mar 06, 2026
Xeris Biopharma Director Sells Shares
Jan 07, 2026
Community Chat
Ask AI
Try asking